We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

French Team Identifies Antidote for Ricin Toxin

By LabMedica International staff writers
Posted on 25 May 2010
A large team of French researchers has discovered two low molecular weight compounds that block the action of ricin, a highly toxic protein often mentioned as a possible bioterror weapon.

Ricin comprises two subunits, the A-chain and the B-chain, which are linked by a disulphide bond. The B-chain facilitates cell entry and intracellular transport, and it is reductively cleaved to free the A-chain, which inactivates ribosomes and shuts down protein synthesis.

Image: Molecular model of the toxic protein ricin (Photo courtesy Laguna Design).
Image: Molecular model of the toxic protein ricin (Photo courtesy Laguna Design).

A French team, headed by investigators at the Centre National de la Recherche Scientifique (Paris, France) used a cell-based assay system to screen over 16,000 compounds for the ability to block the intracellular transport of ricin toxins.

They reported in the April 16, 2010, online edition of the journal Cell that they had identified two compounds, Retro-1 and Retro-2 that were able to inhibit the retrograde transport route of ricin from the plasma membrane to the endoplasmic reticulum. Unlike other compounds that are known to block retrograde transport, Retro-1 and Retro-2 did not affect other intracellular trafficking and did not show any toxicity.

In experiments in mice, Retro-2 was shown to block the activity of ricin, if it were given prior to the toxin. It is expected that these compounds should also inhibit other toxic proteins such as the Shiga-like toxins produced by pathogens such as E. coli, Shigella, and cholera.

Related Links:

Centre National de la Recherche Scientifique



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
Slide Scanner System
NanoZoomer S540MD

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
25 May 2010  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
25 May 2010  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
25 May 2010  |   BioResearch